These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37578111)

  • 1. Dose-tapering trajectories in patients with remitted psychosis undergoing guided antipsychotic reduction to reach minimum effective dose.
    Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
    Eur Psychiatry; 2023 Aug; 66(1):e66. PubMed ID: 37578111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis: a 2-year randomized controlled trial with a naturalistic cohort.
    Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
    Psychol Med; 2023 Nov; 53(15):7078-7086. PubMed ID: 36896797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol of guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis based on pragmatic design.
    Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
    Early Interv Psychiatry; 2022 Feb; 16(2):178-185. PubMed ID: 33751764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
    Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
    Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm.
    Liu CC; Takeuchi H
    CNS Drugs; 2020 Feb; 34(2):117-126. PubMed ID: 31741178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial.
    Moncrieff J; Crellin N; Stansfeld J; Cooper R; Marston L; Freemantle N; Lewis G; Hunter R; Johnson S; Barnes T; Morant N; Pinfold V; Smith R; Kent L; Darton K; Long M; Horowitz M; Horne R; Vickerstaff V; Jha M; Priebe S
    Lancet Psychiatry; 2023 Nov; 10(11):848-859. PubMed ID: 37778356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case series.
    Mølgaard SN; Nielsen MØ; Roed K; Nielsen J
    BMC Psychiatry; 2024 Mar; 24(1):240. PubMed ID: 38553687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
    Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
    Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gradually tapering off antipsychotics: lessons for practice from case studies and neurobiological principles.
    Horowitz MA; Moncrieff J
    Curr Opin Psychiatry; 2024 Jul; 37(4):320-330. PubMed ID: 38726815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials.
    Bogers JPAM; Hambarian G; Walburgh Schmidt N; Vermeulen JM; de Haan L
    Schizophr Bull; 2023 Jan; 49(1):11-23. PubMed ID: 36200866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.
    Wunderink L; Nienhuis FJ; Sytema S; Slooff CJ; Knegtering R; Wiersma D
    J Clin Psychiatry; 2007 May; 68(5):654-61. PubMed ID: 17503973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials.
    Tani H; Takasu S; Uchida H; Suzuki T; Mimura M; Takeuchi H
    Neuropsychopharmacology; 2020 Apr; 45(5):887-901. PubMed ID: 31770770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis.
    Ostuzzi G; Vita G; Bertolini F; Tedeschi F; De Luca B; Gastaldon C; Nosé M; Papola D; Purgato M; Del Giovane C; Correll CU; Barbui C
    Lancet Psychiatry; 2022 Aug; 9(8):614-624. PubMed ID: 35753323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trajectories after first-episode psychosis: Complement to ambiguous outcomes of long-term antipsychotic treatment by exploring a few hidden cases.
    Liu CC; Lin YT; Liu CM; Hsieh MH; Chien YL; Hwang TJ; Hwu HG
    Early Interv Psychiatry; 2019 Aug; 13(4):895-901. PubMed ID: 29927087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
    Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
    Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
    Verhoef LM; van den Bemt BJ; van der Maas A; Vriezekolk JE; Hulscher ME; van den Hoogen FH; Jacobs WC; van Herwaarden N; den Broeder AA
    Cochrane Database Syst Rev; 2019 May; 5(5):CD010455. PubMed ID: 31125448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual working memory deterioration preceding relapse in psychosis.
    Hui CL; Li YK; Li AW; Lee EH; Chang WC; Chan SK; Lam SY; Thornton AE; Sham P; Honer WG; Chen EY
    Psychol Med; 2016 Aug; 46(11):2435-44. PubMed ID: 27305830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.